Cargando…
Prolactin receptor does not correlate with oestrogen and progesterone receptors in primary breast cancer and lacks prognostic significance. Ten year results of the Naples adjuvant (GUN) study.
The correlation between prolactin (PRLR) and oestrogen (ER) or progesterone receptors (PgR) in breast cancer and a possible prognostic significance of PRLR at 10 year follow-up have been investigated in the Naples (GUN) adjuvant trial. A total of 308 pre- and post-menopausal patients with early brea...
Autores principales: | De Placido, S., Gallo, C., Perrone, F., Marinelli, A., Pagliarulo, C., Carlomagno, C., Petrella, G., D'Istria, M., Delrio, G., Bianco, A. R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971484/ https://www.ncbi.nlm.nih.gov/pubmed/2223582 |
Ejemplares similares
-
CMF vs alternating CMF/EV in the adjuvant treatment of operable breast cancer. A single centre randomised clinical trial (Naples GUN-3 study).
por: De Placido, S., et al.
Publicado: (1995) -
Oestrogen and progesterone receptor distribution in the cancerous breast.
por: Panahy, C., et al.
Publicado: (1987) -
The role of oestrogen and progesterone receptors in gigantomastia
por: Kasielska-Trojan, Anna, et al.
Publicado: (2019) -
The role of oestrogen and progesterone receptors in breast cancer – immunohistochemical evaluation of oestrogen and progesterone receptor expression in invasive breast cancer in women
por: Badowska-Kozakiewicz, Anna M., et al.
Publicado: (2015) -
Activation function 1 of progesterone receptor is required for progesterone antagonism of oestrogen action in the uterus
por: Lee, Shi Hao, et al.
Publicado: (2022)